| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A little CFTR can change a lot: slowing cystic fibrosis progression
|
Rowe, Steven M
|
|
|
5 |
2 |
p. 86-87
|
article
|
| 2 |
Are fireworks a hazard for respiratory health?
|
Burki, Talha Khan
|
|
|
5 |
2 |
p. 103-104
|
article
|
| 3 |
Arnold Rice Rich
|
Akkermans, Rebecca
|
|
|
5 |
2 |
p. 102-103
|
article
|
| 4 |
Artist uses patients' experiences to create COPD landscapes
|
Lobo, Patricia
|
|
|
5 |
2 |
p. 101-102
|
article
|
| 5 |
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study
|
Konstan, Michael W
|
|
|
5 |
2 |
p. 107-118
|
article
|
| 6 |
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
|
Montani, David
|
|
|
5 |
2 |
p. 125-134
|
article
|
| 7 |
Clinical trial research in focus: do trials prepare us to deliver precision medicine in those with severe asthma?
|
Brightling, Christopher E
|
|
|
5 |
2 |
p. 92-95
|
article
|
| 8 |
Corrections
|
|
|
|
5 |
2 |
p. e13
|
article
|
| 9 |
Corrections
|
|
|
|
5 |
2 |
p. e13
|
article
|
| 10 |
Cystic fibrosis: a call for papers for the ECFS meeting
|
Grainger, Emma
|
|
|
5 |
2 |
p. 97
|
article
|
| 11 |
Diesel emissions from cars much worse than trucks and buses
|
Burki, Talha Khan
|
|
|
5 |
2 |
p. 98
|
article
|
| 12 |
Interstitial lung abnormalities: risk and opportunity
|
Ash, Samuel Y
|
|
|
5 |
2 |
p. 95-96
|
article
|
| 13 |
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
|
Marty, Francisco M
|
|
|
5 |
2 |
p. 135-146
|
article
|
| 14 |
Is there added value in adding EUS to EBUS?
|
Labarca, Gonzalo
|
|
|
5 |
2 |
p. e8
|
article
|
| 15 |
Is there added value in adding EUS to EBUS? – Authors' reply
|
Korevaar, Daniël A
|
|
|
5 |
2 |
p. e9
|
article
|
| 16 |
Lung volume reduction for emphysema
|
Shah, Pallav L
|
|
|
5 |
2 |
p. 147-156
|
article
|
| 17 |
Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study
|
Yeung, Jonathan C
|
|
|
5 |
2 |
p. 119-124
|
article
|
| 18 |
Pulmonary veno-occlusive disease: characterising a rare but important disease
|
Hadinnapola, Charaka
|
|
|
5 |
2 |
p. 89-90
|
article
|
| 19 |
Racial disparities in critical care: experience from the USA
|
Chertoff, Jason
|
|
|
5 |
2 |
p. e11-e12
|
article
|
| 20 |
Respiratory health in Kosovo: Europe's new nation and a legacy of coal
|
Dumiak, Michael
|
|
|
5 |
2 |
p. 99-100
|
article
|
| 21 |
Sleep apnoea and driving: more clarity needed
|
The Lancet Respiratory Medicine,
|
|
|
5 |
2 |
p. 85
|
article
|
| 22 |
Theranostics in severe influenza
|
Rello, Jordi
|
|
|
5 |
2 |
p. 91-92
|
article
|
| 23 |
The weird and wonderful hunt for a new antibiotic
|
Mohammadi, Dara
|
|
|
5 |
2 |
p. 104-105
|
article
|
| 24 |
Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC
|
Lee, Se-Hoon
|
|
|
5 |
2 |
p. e10
|
article
|
| 25 |
US authorities discourage use of nasal influenza vaccine, citing ineffectiveness
|
Furlow, Bryant
|
|
|
5 |
2 |
p. 105-106
|
article
|
| 26 |
Will ex-vivo lung perfusion allow a move towards daytime lung transplantation surgery?
|
Riddell, Peter
|
|
|
5 |
2 |
p. 88-89
|
article
|
Journal description